Hated Moats Investor (@hatedmoats) 's Twitter Profile
Hated Moats Investor

@hatedmoats

Identifying hated moats. I buy companies when the market panics. Contrarian investor focused on quality, long-term growth. Not advice. See my deep dives here 👇

ID: 1830317662892654592

linkhttps://hatedmoats.substack.com calendar_today01-09-2024 18:53:13

686 Tweet

1,1K Followers

39 Following

Hated Moats Investor (@hatedmoats) 's Twitter Profile Photo

Thrilled to see our deep dive on $ASML translated into French by the excellent Clean Your Finance! 🇫🇷 For all our French-speaking followers, you can read it on his Substack, dropping on Sunday, September 14th. 🇬🇧 The original Hated Moats deep dive can be found here:

Hated Moats Investor (@hatedmoats) 's Twitter Profile Photo

🚨Novo News The Ultimate Moat Expansion? Novo's $15 Billion "Call Option" on Alzheimer's. The news: Novo Nordisk ( $NVO) is expecting results this fall from a major clinical trial testing if their GLP-1 drugs (the class that includes Ozempic and Wegovy) can effectively treat

🚨Novo News

The Ultimate Moat Expansion?

Novo's $15 Billion "Call Option" on Alzheimer's.

The news: Novo Nordisk ( $NVO) is expecting results this fall from a major clinical trial testing if their GLP-1 drugs (the class that includes Ozempic and Wegovy) can effectively treat
Hated Moats Investor (@hatedmoats) 's Twitter Profile Photo

🚨 BREAKING: Is the Novo Nordisk & Eli Lilly duopoly over? 🚨 The FDA just threw a massive curveball at $NVO & $LLY. The News The US FDA announced today it's creating a "green list" of foreign suppliers who meet its standards for producing the raw active ingredients for

🚨 BREAKING:  Is the Novo Nordisk & Eli Lilly duopoly over?  🚨

The FDA just threw a massive curveball at $NVO & $LLY.

The News

The US FDA announced today it's creating a "green list" of foreign suppliers who meet its standards for producing the raw active ingredients for